Focus on coronavirus disease 2019 associated coagulopathy

The coronavirus disease 2019(COVID-19)has caused a global outbreak and became a major public health issue globally.It has been found that COVID-19 patients are commonly complicated with coagulation abnormities,which are closely associated with the severity and prognosis of patients.A thorough understanding of the prevalence of coagulopathy and potential causes of abnormities of coagulation parameters in COVID-19 patients is crucial for clinicians to standardize the diagnosis and management of COVID-19 associated coagulopathy.